ChoA Pharmaceutical (034940) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, ChoA Pharmaceutical (034940) reported revenue of 59.3 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202559.3 billion KRW-6.6 billion KRW-7.4 billion KRW[source]
202462.7 billion KRW-9.6 billion KRW-10.2 billion KRW[source]
202363.0 billion KRW-6.8 billion KRW-11.1 billion KRW[source]
202268.9 billion KRW-482 million KRW515 million KRW[source]
202157.6 billion KRW-7.0 billion KRW-8.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202562.8 billion KRW39.1 billion KRW23.7 billion KRW[source]
202469.8 billion KRW39.6 billion KRW30.2 billion KRW[source]
202374.6 billion KRW32.5 billion KRW42.1 billion KRW[source]
202284.8 billion KRW31.7 billion KRW53.1 billion KRW[source]
202178.7 billion KRW28.0 billion KRW50.8 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice